NCT04933617 2024-07-09Copanlisib With Dose-Adjusted EPOCH-R in Relapsed and Refractory Burkitt Lymphoma and Other High-Grade B-cell LymphomasNational Institutes of Health Clinical Center (CC)Phase 1 Terminated8 enrolled 17 charts